Found 14 matching trials
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001
PHASE1To investigate the dosage of RRx-001 by the subcutaneous route....
Location
Sarah Cannon Research Institute
Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases
PHASE1In this dose-escalation study, the safety and tolerability of escalating do...
Location
Providence Saint John's Health Center
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer
PHASE2This two-stage study is designed to compare the safety and activity between...
Location
UCSD Moores Cancer Center
RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer
PHASE3This Phase 3 study aims to find out whether RRx-001 + platinum chemotherapy...
Location
Centura Health Research Center
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
PHASE2The purpose of this study is to determine if RRx-001, which is added on to ...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PHASE1This is a two-part Phase I add-on clinical trial in newly diagnosed gliobla...
Location
University of California San Francisco (UCSF)
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)
PHASE1This is a phase 1 open-label trial to evaluate the safety, pharmacodynamics...
Location
University of California, Davis
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
PHASE1This is a dose escalation protocol to determine the feasibility of co-admin...
Location
Walter Reed National Military Medical Center
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
PHASE2The purpose of this study is to determine if RRx-001, which is added on to ...
Location
John Wayne Cancer Institute @ Providence St. John's Health Center
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
PHASE1The purpose of this study is to evaluate the safety and pharmacokinetic pro...
Location
Moores University of California San Diego Cancer Center